Dr. Metz is a Penn Medicine employed physician.
Calypso, Medical Advisory Board
Pennsylvania Cancer Education Network Advisory Committee
ProCure Proton Treatment Centers Medical Advisory Board
Recognized in Philadelphia Magazine's 2011 through 2015 Top Docs issues
Dr Metz serves as Chair of Radiation Oncology at the Perelman School of Medicine and holds the Morton M. Kligerman Endowed Professorship. He is Associate Director for Clinical Services and Programs at the Abramson Comprehensive Cancer Center of the University of Pennsylvania. Dr Metz led the development of the Roberts Proton Therapy Center, the largest proton center in the world completely integrated with conventional cancer services. Dr Metz has become an international leader in the application of proton therapy for the treatment of a variety of malignancies. He continues to work to integrate proton therapy as a new treatment paradigm for cancer and is leading the expansion of proton therapy. He also serves as Executive Director OncoLink (www.oncolink.upenn.edu), the award winning Internet resource from the Abramson Comprehensive Cancer Center of the University of Pennsylvania that was founded in 1994. Dr Metz specializes in the use of radiation for the treatment of gastrointestinal malignancies. His research interests include the treatment of GI malignancies in the multidisciplinary setting, as well as the utilization of complementary and alternative medications by cancer patients, and use of the Internet to provide cancer related information. A major area of interest has been the development of proton therapy at Penn and internationally. As Executive Director of OncoLink, Dr Metz leads its mission to help cancer patients, families, health care professionals, and the general public find accurate cancer-related information online. The website has led the way in online education for cancer patients and healthcare providers, receiving numerous awards and recognition from most major authorities as one of the best cancer information websites. Currently OncoLink is developing interactive content and personalized information for individuals while collecting important information to move the field forward, particularly in the area of cancer survivorship. Its reach is international in scope with over 285,000 unique visitors served per month.
A facility of the Hospital of the University of Pennsylvania
A facility of Penn Presbyterian Medical Center
Medical School: University of Medicine and Dentistry of New Jersey
Residency: Cooper University Hospital
Residency: University of Pennsylvania School of Medicine
Penn Radiation Oncology website
internet resource from the Unviersity of Pennsylvania Cancer Center
Editor-in-Chief, OncoLink: internet source for Cancer news and resources from the University of Pennsylvania Cancer Center.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 1-800-789-PENN or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.